Anthony Vendetti
Stock Analyst at Maxim Group
(4.46)
# 285
Out of 4,876 analysts
79
Total ratings
30.99%
Success rate
58.02%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRMA Dermata Therapeutics | Maintains: Buy | $6 → $3 | $0.60 | +396.36% | 4 | May 21, 2025 | |
| NUTX Nutex Health | Maintains: Buy | $100 → $225 | $122.90 | +83.08% | 5 | May 20, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $14 → $10 | $4.86 | +105.76% | 6 | May 19, 2025 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $10 → $5 | $1.49 | +235.57% | 8 | May 8, 2025 | |
| AMIX Autonomix Medical | Initiates: Buy | $5 | $2.01 | +148.76% | 1 | Apr 29, 2025 | |
| BIAF bioAffinity Technologies | Downgrades: Hold | n/a | $0.30 | - | 2 | Apr 1, 2025 | |
| NXL Nexalin Technology | Upgrades: Buy | $5 | $0.92 | +443.48% | 3 | Mar 24, 2025 | |
| SSKN STRATA Skin Sciences | Initiates: Buy | $6 | $2.25 | +166.67% | 1 | Feb 27, 2025 | |
| BHST BioHarvest Sciences | Initiates: Buy | $12 | $6.71 | +78.84% | 1 | Dec 18, 2024 | |
| ACON Aclarion | Downgrades: Hold | n/a | $7.27 | - | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $0.95 | +742.11% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.21 | - | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $50 | $45.89 | +8.96% | 7 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.44 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $7.25 | +727.59% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.22 | +21.65% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $0.79 | +531.23% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.91 | +2,546.09% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.39 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $2.26 | -11.50% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $0.41 | +30,756.58% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.30 | +2,234.11% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $26.52 | -5.73% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.18 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $3,500 | $2.64 | +132,475.76% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $3.77 | +32.63% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.25 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.01 | +197.03% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $15.15 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $120,000 | $4.83 | +2,484,372.05% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $42.39 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.83 | +86,657.44% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.28 | -51.36% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.43 | - | 1 | May 31, 2016 |
Dermata Therapeutics
May 21, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.60
Upside: +396.36%
Nutex Health
May 20, 2025
Maintains: Buy
Price Target: $100 → $225
Current: $122.90
Upside: +83.08%
Sensus Healthcare
May 19, 2025
Maintains: Buy
Price Target: $14 → $10
Current: $4.86
Upside: +105.76%
The Hain Celestial Group
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.49
Upside: +235.57%
Autonomix Medical
Apr 29, 2025
Initiates: Buy
Price Target: $5
Current: $2.01
Upside: +148.76%
bioAffinity Technologies
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.30
Upside: -
Nexalin Technology
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $0.92
Upside: +443.48%
STRATA Skin Sciences
Feb 27, 2025
Initiates: Buy
Price Target: $6
Current: $2.25
Upside: +166.67%
BioHarvest Sciences
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $6.71
Upside: +78.84%
Aclarion
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $7.27
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $0.95
Upside: +742.11%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.21
Upside: -
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $45.89
Upside: +8.96%
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.44
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $60
Current: $7.25
Upside: +727.59%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $8.22
Upside: +21.65%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $0.79
Upside: +531.23%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.91
Upside: +2,546.09%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.39
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $2.26
Upside: -11.50%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $0.41
Upside: +30,756.58%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.30
Upside: +2,234.11%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $26.52
Upside: -5.73%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.18
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $6,000 → $3,500
Current: $2.64
Upside: +132,475.76%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $3.77
Upside: +32.63%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.25
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $1.01
Upside: +197.03%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $15.15
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $120,000
Current: $4.83
Upside: +2,484,372.05%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $42.39
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.83
Upside: +86,657.44%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.28
Upside: -51.36%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $6.43
Upside: -